3 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis Pirfenidone, Placebo oral capsule, Steroids - Systemic Sclerosis | Phase 2 / Phase 3 | Unknown | RenJi Hospital | 72 | 2017-05-01 | 2017-03-01 |
| Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis Probiotic, Placebo - Systemic Sclerosis, Scleroderma | Phase 3 | Unknown | Federal University of São Paulo | 76 | 2014-12-01 | 2014-11-27 |
Scleroderma, Systemic (3) · Scleroderma, Diffuse (2) · Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Systemic Vasculitis (1) · Undifferentiated Connective Tissue Diseases (1)
Connective Tissue Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Arthritis (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Rheumatic Diseases (1) · Vascular Diseases (1) · Vasculitis (1)
COVID-19 Vaccines (1) · Probiotics (1) · Steroids (1) · pirfenidone (1)
Federal University of São Paulo (1) · Paul R Fortin (1) · RenJi Hospital (1)
Brazil (1) · Canada (1) · China (1)
Cristiane Kayser (1) · Paul R Fortin, MD,MPH,FRCPC (1)